Amgen SVP granted RSUs and stock options
Amgen Inc. senior vice president of human resources Derek Miller reported routine equity compensation activity.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Amgen Inc. senior vice president of human resources Derek Miller reported routine equity compensation activity. He received 910 shares of common stock as a grant, which the footnotes describe as Restricted Stock Units that vest in four equal annual installments of 25% starting on May 5, 2027, and include 116 Dividend Equivalents credited under Amgen’s equity incentive plan.
He was also granted 5,938 non-qualified stock options with an exercise price of $329.59 per share, vesting 25% per year from May 5, 2027 until expiration on May 5, 2036. Separately, 123 shares of common stock were disposed of at $329.59 per share to cover tax obligations, a non-market tax-withholding transaction. After these transactions, Miller directly holds 12,595 Amgen shares.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Miller Derek
Role
SVP, Human Resources
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 123 | $329.59 | $41K |
| Grant/Award | Nqso (Right to Buy) | 5,938 | $329.59 | $1.96M |
| Grant/Award | Common Stock | 910 | $0.00 | $0.00 |
Holdings After Transaction:
Nqso (Right to Buy) — 5,938 contracts (Direct);
Common Stock — 12,595 shares (Direct)
Footnotes (3)
- F1. The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- F2. These shares include 116 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
- F3. These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027.
Key Figures
RSU-related stock grant: 910 shares
Dividend Equivalents included: 116 shares
Non-qualified stock options granted: 5,938 options
+5 more
8 metrics
RSU-related stock grant
910 shares
Restricted Stock Units vesting 25% annually from May 5, 2027
Dividend Equivalents included
116 shares
Credited to unvested RSUs under the equity incentive plan
Non-qualified stock options granted
5,938 options
Right to buy Amgen common stock
Option exercise price
$329.59/share
Non-qualified stock options granted May 5, 2026
Option vesting schedule
25% annually
Vesting begins May 5, 2027 and continues for four years
Tax-withholding disposition
123 shares
Shares withheld at $329.59 to satisfy tax liability
Post-transaction holdings
12,595 shares
Direct Amgen common stock owned after the reported transactions
Option expiration
May 5, 2036
Expiration date of non-qualified stock options
Key Terms
Restricted Stock Units (RSUs), Dividend Equivalents (DEs), non-qualified stock options, Equity Incentive Plan, +1 more
5 terms
Restricted Stock Units (RSUs) financial
"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Dividend Equivalents (DEs) financial
"These shares include 116 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan"
non-qualified stock options financial
"These non-qualified stock options were granted pursuant to the Equity Incentive Plan"
Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.
Equity Incentive Plan financial
"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan)"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
Dividend Equivalents financial
"DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares"
Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Amgen (AMGN) executive Derek Miller report in this Form 4 filing?
Derek Miller reported routine equity compensation activity, including a stock grant and stock option grant, plus a small share disposition for taxes. These transactions reflect standard executive compensation rather than open-market buying or selling of Amgen stock.
What stock options were granted to Derek Miller by Amgen (AMGN)?
Miller was granted 5,938 non-qualified stock options to buy Amgen common stock at an exercise price of $329.59 per share. These options vest in four equal annual installments starting May 5, 2027 and expire on May 5, 2036, subject to plan terms.
How do Derek Miller’s Amgen (AMGN) RSUs vest over time?
The Restricted Stock Units vest in four equal annual installments of 25% each, starting May 5, 2027. Once vested, each RSU pays out one share of Amgen common stock, and related Dividend Equivalents are also paid in shares with fractional amounts settled in cash.
AI-generated analysis. How Rhea-AI works. Not financial advice.
